Aaron R. Hansen, David A. Pattison, Jeffrey C. Goh, Stanley S. Ngai, Aravind S. Ravi Kumar, Chun Loo Gan, Anna Kuchel, Robert B. Mason, Loren Katchel, Louise Campbell, Jasmine Brady, Nathan Papa, Paola M. Santoro, Megan A. Crumbaker, Meghan C. Baronet, Anna M. Karmann and David K. Wyld
Read the full article here: TheraPb Phase 1b: First-in-Human Dose-Escalation and Optimization Study of 212Pb-ADVC001 in PSMA-Positive Metastatic Androgen Pathway Modulation–Resistant Prostate Cancer | Journal of Nuclear Medicine

